XML 21 R10.htm IDEA: XBRL DOCUMENT v3.24.3
Note C - Revenues
6 Months Ended
Sep. 29, 2024
Notes to Financial Statements  
Revenue from Contract with Customer [Text Block]

NOTE C – REVENUES

 

The Company’s disaggregated revenues for the thirteen and twenty-six weeks ended September 29, 2024 and September 24, 2023 are as follows (in thousands):

 

   

Thirteen weeks ended

   

Twenty-six weeks ended

 
   

September 29,

2024

   

September 24,

2023

   

September 29,

2024

   

September 24,

2023

 
                                 

Branded Products

  $ 24,536     $ 23,352     $ 50,682     $ 48,522  

Company-owned restaurants

    5,348       5,193       9,547       8,851  

License royalties

    9,491       8,339       22,412       19,997  

Franchise royalties

    1,066       1,148       2,047       2,128  

Franchise fees

    108       143       200       238  

Advertising fund revenue

    560       569       988       993  

Total revenues

  $ 41,109     $ 38,744     $ 85,876     $ 80,729  

 

The following table disaggregates revenues by primary geographical market (in thousands):

 

   

Thirteen weeks ended

   

Twenty-six weeks ended

 
   

September 29, 2024

   

September 24, 2023

   

September 29, 2024

   

September 24, 2023

 
                                 

United States

  $ 40,464     $ 37,444     $ 83,760     $ 77,326  

International

    645       1,300       2,116       3,403  

Total revenues

  $ 41,109     $ 38,744     $ 85,876     $ 80,729  

 

Contract balances

 

The following table provides information about contract liabilities from contracts with customers (in thousands):

 

   

September 29, 2024

   

March 31, 2024

 

Deferred franchise fees (a)

  $ 1,101     $ 1,226  

Deferred revenues, which are included in

               

“Accrued expenses and other current liabilities” (b)

  $ 600     $ 1,375  

 

 

(a)

Deferred franchise fees of $318 and $783 as of September 29, 2024 and $327 and $899 as of March 31, 2024 are included in Deferred franchise fees – current and long term, respectively.

 

(b)

Includes $100 of deferred license royalties and $500 of deferred advertising fund revenue as of September 29, 2024 and $875 of deferred license royalties and $500 of deferred advertising fund revenue as of March 31, 2024.

 

Significant changes in deferred franchise fees are as follows (in thousands):

 

   

Twenty-six weeks ended

 
   

September 29, 2024

   

September 24, 2023

 

Deferred franchise fees at beginning of period

  $ 1,226     $ 1,608  

New deferrals due to cash received and other

    75       46  

Revenue recognized during the period

    (200 )     (238 )

Deferred franchise fees at end of period

  $ 1,101     $ 1,416  

 

 

Significant changes in deferred revenues are as follows (in thousands):

 

   

Twenty-six weeks ended

 
   

September 29, 2024

   

September 24, 2023

 

Deferred revenues at beginning of period

  $ 1,375     $ 1,406  

New deferrals due to cash received and other

    500       500  

Revenue recognized during the period

    (1,275 )     (1,164 )

Deferred revenues at end of period

  $ 600     $ 742  

 

Anticipated future recognition of deferred franchise fees

 

The following table reflects the estimated franchise fees to be recognized in the future related to performance obligations that are unsatisfied at the end of the period (in thousands):

 

   

Estimate for fiscal year

 

2025 (a)

  $ 165  

2026

    303  

2027

    189  

2028

    93  

2029

    62  

Thereafter

    289  

Total

  $ 1,101  

 

 

(a)

Represents franchise fees expected to be recognized for the remainder of the 2025 fiscal year, which includes international development fees expected to be recognized over the duration of one year or less. Amount does not include $200 of franchise fee revenue recognized for the twenty-six weeks ended September 29, 2024.

 

We have applied the optional exemption, as provided for under ASC Topic 606 “Revenues from Contracts with Customers,” which allows us to not disclose the transaction price allocated to unsatisfied performance obligations when the transaction price is a sales-based royalty.